Cargando…

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)

Detalles Bibliográficos
Autores principales: Uldrick, Thomas, Polizzotto, Mark, O’Mahony, Deirdre, Aleman, Karen, Wyvill, Kathy, Steinberg, Seth M, Pittaluga, Stefania, Marshall, Vickie, Whitby, Denise, Tosato, Giovanna, Little, Richard F, Yarchoan, Robert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002735/
http://dx.doi.org/10.1186/1750-9378-5-S1-A72
_version_ 1782193774877736960
author Uldrick, Thomas
Polizzotto, Mark
O’Mahony, Deirdre
Aleman, Karen
Wyvill, Kathy
Steinberg, Seth M
Pittaluga, Stefania
Marshall, Vickie
Whitby, Denise
Tosato, Giovanna
Little, Richard F
Yarchoan, Robert
author_facet Uldrick, Thomas
Polizzotto, Mark
O’Mahony, Deirdre
Aleman, Karen
Wyvill, Kathy
Steinberg, Seth M
Pittaluga, Stefania
Marshall, Vickie
Whitby, Denise
Tosato, Giovanna
Little, Richard F
Yarchoan, Robert
author_sort Uldrick, Thomas
collection PubMed
description
format Text
id pubmed-3002735
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30027352010-12-16 Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) Uldrick, Thomas Polizzotto, Mark O’Mahony, Deirdre Aleman, Karen Wyvill, Kathy Steinberg, Seth M Pittaluga, Stefania Marshall, Vickie Whitby, Denise Tosato, Giovanna Little, Richard F Yarchoan, Robert Infect Agent Cancer Meeting Abstracts BioMed Central 2010-10-11 /pmc/articles/PMC3002735/ http://dx.doi.org/10.1186/1750-9378-5-S1-A72 Text en Copyright ©2010 Uldrick et al; licensee BioMed Central Ltd.
spellingShingle Meeting Abstracts
Uldrick, Thomas
Polizzotto, Mark
O’Mahony, Deirdre
Aleman, Karen
Wyvill, Kathy
Steinberg, Seth M
Pittaluga, Stefania
Marshall, Vickie
Whitby, Denise
Tosato, Giovanna
Little, Richard F
Yarchoan, Robert
Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
title Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
title_full Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
title_fullStr Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
title_full_unstemmed Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
title_short Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
title_sort rituximab combined with liposomal doxorubicin (r-dox) in hiv-infected patients with severe kaposi sarcoma-associated herpes virus (kshv) associated multicentric castleman disease (mcd)
topic Meeting Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002735/
http://dx.doi.org/10.1186/1750-9378-5-S1-A72
work_keys_str_mv AT uldrickthomas rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT polizzottomark rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT omahonydeirdre rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT alemankaren rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT wyvillkathy rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT steinbergsethm rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT pittalugastefania rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT marshallvickie rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT whitbydenise rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT tosatogiovanna rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT littlerichardf rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd
AT yarchoanrobert rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd